Imaging tests to better predict and diagnose gynecologic cancers
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial studies how well medical imaging (especially MRI) can help predict outcomes and improve diagnosis in people newly diagnosed with certain gynecologic cancers. It may help doctors make more accurate treatment decisions by comparing imaging results to the final cancer type and stage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You have newly diagnosed (not previously treated) cervical, endometrial, or strongly suspected epithelial ovarian cancer
- Your cancer stage (FIGO stage) is known
- You have not had another cancer (other than the current one) in the past 10 years
- You can safely have an MRI (no MRI-incompatible implants/devices and you’re able to complete the scan)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special PET scans to better see and understand pelvic tumors. It may help doctors plan treatment more accurately. You may be able to join if you have a pelvic tumor and can have surgery or a biopsy.
This study tests a special imaging agent (89Zr-DFO-Mirvetuximab) that may help doctors see ovarian cancer more clearly on PET/CT scans. It is for people with advanced or recurring ovarian cancer to assess if the drug is safe and effective for imaging.
This trial tests a new PET scan tracer that targets a protein found on certain cancer cells. It may help doctors better see and understand tumors in people with colorectal, gastric, pancreatic, lobular breast, or ovarian cancer.
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
This Phase 2 study uses a special MRI scan (hyperpolarized carbon-13) to look at how well immunotherapy works in gynecologic cancers. You may be able to help researchers better understand treatment response, if you meet the study health and scan-safety requirements.
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
Hear when a new Cervix Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.